Ukko, Inc., a biotechnology company re-inventing immunotherapy for allergic diseases, today announced a summary of 2025 operational achievements and provided a strategic outlook for 2026. "2026 is ...
This is part two of a three-part Healio Exclusive series on work-life balance among women physicians. Part one can be viewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback